Neurocrine Biosciences (NASDAQ:NBIX) Shares Gap Up on Analyst Upgrade
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) shares gapped up prior to trading on Tuesday after Royal Bank of Canada raised their price target on the stock from $137.00 to $145.00. The stock had previously closed at $109.75, but opened at $123.00. Royal Bank of Canada currently has an outperform rating on the stock. […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) shares gapped up prior to trading on Tuesday after Royal Bank of Canada raised their price target on the stock from $137.00 to $145.00. The stock had previously closed at $109.75, but opened at $123.00. Royal Bank of Canada currently has an outperform rating on the stock. […]
-logo-1200x675.png?v=20230920074015&w=240&h=240&zc=2){kind=logo}
